Jyothy Labs is set to review its Q4 and full-year financial results for FY26, as well as potentially recommend a dividend for shareholders, during a board meeting on May 4, 2026.

Despite evidence of stable growth, Jyothy Labs has seen a 30% drop in stock price over the year, trailing behind its FMCG peers. However, its strong points include a debt-free status and an appealing valuation at 24x forward earnings, with an enhanced product mix contributing positively to its balance sheet.